^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    LMB-2

    i
    Other names: LMB-2, Anti-Tac(Fv)-PE38, Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin
    Associations
    News
    Trials
    Company:
    National Cancer Institute
    Drug class:
    IL-2R antagonist
    Related drugs:
    Associations
    News
    Trials